Catalyst Wire Dossier Catalyst Wire Dossier

Disodium cromoglycate + reproterol fixed combination

· MEDA Pharma GmbH & Co. KG
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Disodium cromoglycate + reproterol fixed combination, covering 2022-02-07 to 2022-02-07. Get the full timeline:

Most recent: Clinical Trial Update: To Assess the Protective Effect of the Fixed Drug Combination of Disodium Cromoglycate Plus Reproterol [Phase 2]

See pricing